Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong
· Delayed Price · Currency is HKD 17.80
+1.40 (8.54%)
May 30, 2025, 4:08 PM HKT
HKG:2315 Market Cap
HKG:2315 has a market cap or net worth of 7.11 billion as of May 30, 2025. Its market cap has increased by 73.49% in one year.
Market Cap
7.11B
Enterprise Value
7.28B
Revenue
1.04B
Ranking
n/a
PE Ratio
198.48
Stock Price
17.80
Market Cap Chart
Since September 1, 2022, HKG:2315's market cap has decreased from 10.31B to 7.11B, a decrease of -31.07%. That is a compound annual growth rate of -12.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 7.11B | 109.41% |
| Dec 31, 2024 | 3.39B | -29.05% |
| Dec 29, 2023 | 4.78B | -53.29% |
| Dec 30, 2022 | 10.24B | -0.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 221.13B |
| Hansoh Pharmaceutical Group Company | 152.51B |
| JD Health International | 132.80B |
| Innovent Biologics | 99.30B |
| WuXi Biologics | 95.12B |
| CSPC Pharmaceutical Group | 77.94B |
| Akeso | 74.99B |
| Sino Biopharmaceutical | 74.97B |